Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington’s disease
Alba Di Pardo(Istituto Neurologico Mediterraneo), Vittorio Maglione(University of Alberta)
Cited by 78
Related Papers
Impaired Ganglioside Metabolism in Huntington's Disease and Neuroprotective Role of GM1
|Journal of Neuroscience|2010|142
Sphingolipid Metabolism: A New Therapeutic Opportunity for Brain Degenerative Disorders
|Frontiers in Neuroscience|2018|77